SupplySide Global 2026: Wecare Probiotics scales up production and launches CDMO services
13 Nov 2026 | Wecare Probiotics
Dr. George Zhou, director of applied technology at Wecare Probiotics, introduced the company’s new client services in research and contract development and manufacturing (CDMO), supporting customers with clinical studies and regulatory solutions for probiotic strains. He shared clinical research on gummies with Wecare Probiotics’ Weizmannia coagulans BC99 strain, showing benefits for immunity in adults and children. Zhou also highlighted the company’s latest facility expansion, which adds 500 metric tons of probiotic production capacity annually.
